研发与开发
research and development
研发与开发
research and development
锘恩科德公司始终坚信科技是第一生产力，投入大量人力物力进行技术研发，建立理企业自身的独立研发机构。目前特种生物蛋白制品研究所在研应用性项目集中于心血管疾病、抗肿瘤、抗自身免疫性疾病等方面，并已取得阶段性进展。我公司注重基础研究，自行开发的色谱分离纯化技术，在获得蛇毒中的多种单体活性物质方面，具有产品纯度高，活性高，工艺稳定，得率高等特点；公司在基因工程、微生物发酵工程、分离纯化工程技术上拥有扎实积累，系统研发出了辅酶系列的产业化制备技术。我公司凭借系统化的投入，在多个领域达到国内先进水平，为综合开发利用蛇毒为代表的特种生物蛋白资源打下了坚实基础。
Science and technology constitute the primary productive force. NuoEnKeDe has invested a large number of manpower and material resources to carry forward technology research and development. Now, NuoEnKeDe’s research institution is bent on cardiovascular disease, antineoplastic, autoimmune disease etc., by special biological proteins. At the same time, NuoEnKeDe has developed a set of separation and purification techniques to extract many kinds of active monomers from snake venom, with highest purity and activity in China. In addition, NuoEnKeDe has also developed a set of preparation technology of reduced coenzymⅠ and reduced coenzymⅡ, a new separation and purification system, likewise, highest purity and activity in China. So in the field of biological proteins, NuoEnKeDe has built solid foundation for comprehensive development and utilization.